Literature DB >> 19070210

Measurement of neutron ambient dose equivalent in passive carbon-ion and proton radiotherapies.

Shunsuke Yonai1, Naruhiro Matsufuji, Tatsuaki Kanai, Yuki Matsui, Kaoru Matsushita, Haruo Yamashita, Masumi Numano, Takeji Sakae, Toshiyuki Terunuma, Teiji Nishio, Ryosuke Kohno, Takashi Akagi.   

Abstract

Secondary neutron ambient dose equivalents per the treatment absorbed dose in passive carbon-ion and proton radiotherapies were measured using a rem meter, WENDI-II at two carbon-ion radiotherapy facilities and four proton radiotherapy facilities in Japan. Our measured results showed that (1) neutron ambient dose equivalent in carbon-ion radiotherapy is lower than that in proton radiotherapy, and (2) the difference to the measured neutron ambient dose equivalents among the facilities is within a factor of 3 depending on the operational beam setting used at the facility and the arrangement of the beam line, regardless of the method for making a laterally uniform irradiation field: the double scattering method or the single-ring wobbling method. The reoptimization of the beam line in passive particle radiotherapy is an effective way to reduce the risk of secondary cancer because installing an adjustable precollimator and designing the beam line devices with consideration of their material, thickness and location, etc., can significantly reduce the neutron exposure. It was also found that the neutron ambient dose equivalent in passive particle radiotherapy is equal to or less than that in the photon radiotherapy. This result means that not only scanning particle radiotherapy but also passive particle radiotherapy can provide reduced exposure to normal tissues around the target volume without an accompanied increase in total body dose.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19070210     DOI: 10.1118/1.2989019

Source DB:  PubMed          Journal:  Med Phys        ISSN: 0094-2405            Impact factor:   4.071


  17 in total

1.  An analytic model of neutron ambient dose equivalent and equivalent dose for proton radiotherapy.

Authors:  Rui Zhang; Angélica Pérez-Andújar; Jonas D Fontenot; Phillip J Taddei; Wayne D Newhauser
Journal:  Phys Med Biol       Date:  2010-11-12       Impact factor: 3.609

2.  Assessment of out-of-field absorbed dose and equivalent dose in proton fields.

Authors:  Ben Clasie; Andrew Wroe; Hanne Kooy; Nicolas Depauw; Jay Flanz; Harald Paganetti; Anatoly Rosenfeld
Journal:  Med Phys       Date:  2010-01       Impact factor: 4.071

3.  Monte Carlo and analytical model predictions of leakage neutron exposures from passively scattered proton therapy.

Authors:  Angélica Pérez-Andújar; Rui Zhang; Wayne Newhauser
Journal:  Med Phys       Date:  2013-12       Impact factor: 4.071

4.  Secondary neutron spectrum from 250-MeV passively scattered proton therapy: measurement with an extended-range Bonner sphere system.

Authors:  Rebecca M Howell; E A Burgett
Journal:  Med Phys       Date:  2014-09       Impact factor: 4.071

Review 5.  Neutron dose and its measurement in proton therapy-current State of Knowledge.

Authors:  Roger Antoine Hälg; Uwe Schneider
Journal:  Br J Radiol       Date:  2020-01-21       Impact factor: 3.039

Review 6.  Assessment of the risk for developing a second malignancy from scattered and secondary radiation in radiation therapy.

Authors:  Harald Paganetti
Journal:  Health Phys       Date:  2012-11       Impact factor: 1.316

7.  Reduction of the secondary neutron dose in passively scattered proton radiotherapy, using an optimized pre-collimator/collimator.

Authors:  David J Brenner; Carl D Elliston; Eric J Hall; Harald Paganetti
Journal:  Phys Med Biol       Date:  2009-09-24       Impact factor: 3.609

8.  Ambient neutron and photon dose equivalent H*(10) around a pencil beam scanning proton therapy facility.

Authors:  Dayananda Shamurailatpam Sharma; Kartikeswar Ch Patro; Noufal Manthala Padannayel; Manikandan Arjunan; Ganapathy Krishnan; Rajesh Thiyagarajan; Srinivas Chilukuri; Rakesh Jalali
Journal:  Br J Radiol       Date:  2019-07-23       Impact factor: 3.039

9.  Influence of secondary neutrons induced by proton radiotherapy for cancer patients with implantable cardioverter defibrillators.

Authors:  Takayuki Hashimoto; Tomonori Isobe; Haruko Hashii; Hiroaki Kumada; Hiroshi Tada; Toshiyuki Okumura; Koji Tsuboi; Takeji Sakae; Kazutaka Aonuma; Hideyuki Sakurai
Journal:  Radiat Oncol       Date:  2012-01-29       Impact factor: 3.481

10.  Assessment of organ dose reduction and secondary cancer risk associated with the use of proton beam therapy and intensity modulated radiation therapy in treatment of neuroblastomas.

Authors:  Hiroshi Fuji; Uwe Schneider; Yuji Ishida; Masahiro Konno; Haruo Yamashita; Yuki Kase; Shigeyuki Murayama; Tsuyoshi Onoe; Hirofumi Ogawa; Hideyuki Harada; Hirofumi Asakura; Tetsuo Nishimura
Journal:  Radiat Oncol       Date:  2013-11-01       Impact factor: 3.481

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.